Summit Financial’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Sell
30,000
-14,046
-32% -$99.2K ﹤0.01% 1325
2025
Q4
$218K Sell
44,046
-7,564
-15% -$31.9K ﹤0.01% 1217
2025
Q3
$233K Buy
+51,610
New +$176K ﹤0.01% 1154

Other funds holding DRTS

Summit Financial's DRTS Position: Q1 2026 in Review

Summit Financial reduced its Alpha Tau Medical (DRTS) stake by 32% in Q1 2026, selling an estimated $99.2K and leaving 30,000 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Summit Financial first reported a position in DRTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $233K in Q3 2025. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Summit Financial held 30,000 shares of Alpha Tau Medical worth $212K as of Q1 2026.
  • Summit Financial sold 14,046 Alpha Tau Medical shares in Q1 2026, an estimated $99.2K.
  • Alpha Tau Medical made up ﹤0.01% of Summit Financial's portfolio in Q1 2026, its #1325 holding.
  • Summit Financial first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 3 quarters since.
  • Summit Financial's Alpha Tau Medical position peaked at $233K in Q3 2025.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.